Monosialotetrahexosylganglioside sodium combined with hyperbaric oxygen on nervous system development and brain physiology in children with hypoxic ischemic encephalopathy.

What Researchers Did

Researchers investigated the effects of monosialotetrahexosylganglioside sodium (GM1) combined with hyperbaric oxygen in 80 children with neonatal hypoxic ischaemic encephalopathy, divided into two groups.

What They Found

The study found no significant differences in neuron-specific enolase (NSE) levels or amplitude-integrated electroencephalogram (aEEG) scores between the two groups for children with mild severity after treatment. The provided abstract was incomplete, preventing a full report of the study's short-term and long-term clinical effects, including mental and psychomotor development indices.

Canadian Relevance

This study has no direct Canadian connection as it was conducted outside of Canada.

Study Limitations

A significant limitation is the truncated abstract, which prevents a comprehensive understanding of the study's full results and conclusions.